Viral pneumonia is treated primarily with rest, fluids, and supportive care, though specific antiviral medications can help when the virus is identified early. Most mild cases resolve at home in one to two weeks, while severe cases may require hospitalization for oxygen support or more aggressive interventions. The right treatment depends on which virus is responsible, how severe your symptoms are, and how quickly you start.
Supportive Care Is the Foundation
For most people with viral pneumonia, treatment looks a lot like treating a bad flu: rest, staying hydrated, and managing symptoms like fever and body aches with over-the-counter pain relievers. Unlike bacterial pneumonia, which responds to antibiotics, viral pneumonia has to run its course while your immune system fights off the infection. The goal of supportive care is to keep you comfortable and prevent complications while that happens.
Staying hydrated matters more than people realize. Fever and rapid breathing both increase fluid loss, and dehydration makes it harder for your body to clear mucus from the lungs. If you’re recovering at home, drinking water and clear fluids consistently throughout the day is one of the most useful things you can do. Over-the-counter fever reducers also serve a double purpose: they bring your temperature down and reduce the general achiness that makes it hard to rest.
Antivirals That Target Specific Viruses
When doctors can identify the virus causing pneumonia, targeted antiviral medications become an option. These drugs don’t cure pneumonia overnight, but they can shorten the illness, reduce severity, and lower the risk of complications. The catch is that most of them work best when started early.
For influenza-related pneumonia, oseltamivir (commonly known as Tamiflu) is the standard antiviral. It works by blocking a protein on the surface of the flu virus that allows it to spread from cell to cell. The critical detail: it needs to be started within 48 hours of your first symptoms. Beyond that window, its effectiveness has not been established. This is why getting tested quickly when you suspect the flu matters, especially if you’re in a higher-risk group.
For COVID-19 pneumonia, both remdesivir and the oral combination of nirmatrelvir with ritonavir (Paxlovid) have full FDA approval. Which one a doctor recommends depends on how sick you are. Milder cases caught early may be treated with the oral option at home, while remdesivir is typically given through an IV in a hospital setting for more severe illness. COVID-19 vaccines remain the strongest tool for preventing pneumonia from developing in the first place, reducing your risk of hospitalization and critical illness even when breakthrough infections occur.
Other antivirals exist for less common causes. Acyclovir treats pneumonia caused by herpes-family viruses, while ribavirin and ganciclovir are reserved for specific situations like RSV in immunocompromised patients or cytomegalovirus infections. These are relatively uncommon scenarios, but they highlight why identifying the virus is so important for choosing the right treatment.
When Antibiotics Enter the Picture
Antibiotics don’t work against viruses, but they still play a role in managing viral pneumonia. The reason: secondary bacterial infections are a real and common threat. During the COVID-19 pandemic, roughly 15% of hospitalized patients developed a bacterial infection on top of their viral one, and in critically ill patients, that number climbed as high as 50%.
When viral pneumonia damages the lining of the lungs, bacteria that would normally be harmless can take hold and cause a second, overlapping infection. This is why nearly all seriously ill patients with viral pneumonia receive antibiotics, not to fight the virus, but to prevent or treat bacterial complications. If you’re recovering at home and your symptoms suddenly worsen after seeming to improve, a secondary bacterial infection is one of the things your doctor will consider.
Oxygen Support for Severe Cases
Pneumonia interferes with the lungs’ ability to transfer oxygen into the bloodstream, and in severe cases, supplemental oxygen becomes essential. The type of oxygen support you receive depends on how much help your lungs need.
The simplest option is a standard nasal cannula, the small plastic tubing that hooks over your ears and delivers oxygen through two prongs in your nostrils. It provides a modest boost, raising the oxygen concentration you breathe from the normal 21% in room air up to about 45%. For patients who need more, a non-rebreather mask with a reservoir bag can push that concentration to 60-90%.
High-flow nasal cannula systems represent a step up, delivering heated, humidified oxygen at very high flow rates and concentrations up to 100%. These systems have become a go-to option for patients with significant breathing difficulty because they’re more comfortable than a face mask and can sometimes prevent the need for a ventilator. When none of these are enough, non-invasive pressure masks (BiPAP) or, in the most critical cases, mechanical ventilation through a breathing tube become necessary.
How Doctors Decide on Hospitalization
Not everyone with viral pneumonia needs to be in a hospital. Doctors use severity scoring systems to make that call. One of the most widely used is the CURB-65 score, which assigns one point each for five risk factors: confusion, elevated blood urea levels, a respiratory rate of 30 or more breaths per minute, low blood pressure, and age 65 or older.
A score of 0 or 1 means low risk, with less than a 3% chance of dying within 30 days, and home treatment is usually appropriate. A score of 2 puts you in moderate-risk territory, where a short hospital stay or closely supervised outpatient care makes sense. A score of 3 or higher signals serious danger, with mortality risk above 15%, and warrants urgent hospital admission.
Monitoring at Home With a Pulse Oximeter
If you’re recovering from viral pneumonia at home, a pulse oximeter (the small clip that goes on your fingertip) is genuinely useful. It measures the oxygen saturation in your blood, giving you an early warning if your lungs are struggling more than you can feel.
Normal oxygen saturation is 95% or above. If your readings drop below 92%, contact your doctor, as this can signal that your lungs aren’t keeping up. If readings fall to 88% or lower, seek immediate medical attention. Keep in mind that pulse oximeters can be less accurate on darker skin tones and with cold fingers or nail polish, so take readings when your hands are warm and your nails are bare.
What Recovery Actually Looks Like
Some people with mild viral pneumonia feel better and return to their normal routines within one to two weeks. For others, especially older adults or those who were hospitalized, recovery can take a month or longer. Fatigue tends to be the most stubborn symptom. Most people continue to feel unusually tired for about a month, even after the cough and fever have resolved.
Light physical activity during recovery helps. Moving around, even short walks, can rebuild strength and improve lung function. But don’t be alarmed if you still feel short of breath during exertion for several weeks. Your lungs need time to fully heal, and pushing too hard too soon can slow that process. Gradually increasing your activity level, rather than jumping back to your pre-illness routine, is the more reliable path back to normal.
Vaccines That Prevent Viral Pneumonia
The most effective treatment for viral pneumonia is avoiding it altogether. Annual flu vaccines, updated COVID-19 vaccines, and RSV immunizations all reduce your risk of the severe respiratory infections that lead to pneumonia. These vaccines don’t guarantee you won’t get infected, but their main strength is preventing the kind of severe illness that lands people in the hospital. COVID-19 vaccines also reduce the chance of developing long COVID. RSV immunizations can reduce hospitalization risk in both infants and older adults, the two groups most vulnerable to that particular virus.